Literature DB >> 25135599

Behavioral and neurochemical changes induced by repetitive combined treatments of ketamine and amphetamine in mice.

Chuan-Ching Lai1, Li-Jen Lee, Hsiang-Shu Yin.   

Abstract

The combined abuse of recreational drugs such as ketamine (Ket) and amphetamine (Amph) should be seriously considered important social and health issues. Numerous studies have documented the behavioral and neurochemical changes associated with polydrug administration; however, most studies have only examined the acute effects. The consequences following chronic repetitive polydrug use are less studied. In the present study, intraperitoneal injections of saline, Amph (5 mg/kg), low dose Ket (LK, 10 mg/kg), high dose Ket (HK, 50 mg/kg), or Amph plus LK or HK (ALK or AHK) were conducted twice a day for three consecutive days, and one final treatment was administered on day 4. After seven total treatments, animal behaviors, including locomotion, stereotypy and ataxia, were examined in a novel open field. The expression of GAD67 and dopamine (DA) levels were assessed in the striatum and motor-related cortices using immunohistochemistry and high-performance liquid chromatography. Drug-induced hyperactivities and Amph-mediated potentiation of Ket-triggered ataxia manifested after repeated drug treatments. A significant increase in the number of GAD67-positive puncta in the striatum and motor-related cortices was observed, suggesting a neural adaptive change in the GABAergic system. Four hours after the final treatment, while the behavioral hyperactivities had ceased, considerable changes were still evident in the motor-related cortices, suggesting modulation to the DAergic system. Together, our results show the interactive effects of these two drugs in behavioral and neurochemical aspects and neural adaptive changes in the GABAergic and DAergic systems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135599     DOI: 10.1007/s11064-014-1419-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  52 in total

1.  Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine.

Authors:  N G Bacopoulos; D E Redmond; R H Roth
Journal:  J Neurochem       Date:  1979-04       Impact factor: 5.372

Review 2.  Neuroadaptations involved in amphetamine and cocaine addiction.

Authors:  F J White; P W Kalivas
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

3.  Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

Authors:  C Ikonomidou; F Bosch; M Miksa; P Bittigau; J Vöckler; K Dikranian; T I Tenkova; V Stefovska; L Turski; J W Olney
Journal:  Science       Date:  1999-01-01       Impact factor: 47.728

4.  Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

Authors:  N Lindefors; S Barati; W T O'Connor
Journal:  Brain Res       Date:  1997-06-13       Impact factor: 3.252

Review 5.  Amphetamine: effects on catecholamine systems and behavior.

Authors:  L S Seiden; K E Sabol; G A Ricaurte
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

6.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

7.  Patterns of use and harms associated with non-medical ketamine use.

Authors:  Paul Dillon; Jan Copeland; Karl Jansen
Journal:  Drug Alcohol Depend       Date:  2003-01-24       Impact factor: 4.492

8.  DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains.

Authors:  Christina H Liu; Jia Q Ren; Jinsheng Yang; Charng-ming Liu; Joseph B Mandeville; Bruce R Rosen; Pradeep G Bhide; Yuchio Yanagawa; Philip K Liu
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

Review 9.  Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance.

Authors:  A Hitri; Y L Hurd; R J Wyatt; S I Deutsch
Journal:  Clin Neuropharmacol       Date:  1994-02       Impact factor: 1.592

Review 10.  Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models.

Authors:  Gavin P Reynolds; Zuhal Abdul-Monim; Joanna C Neill; Zhi-Jun Zhang
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

View more
  1 in total

1.  Action sequencing in the spontaneous swimming behavior of zebrafish larvae - implications for drug development.

Authors:  Tobias Palmér; Fredrik Ek; Olof Enqvist; Roger Olsson; Kalle Åström; Per Petersson
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.